Showing results 1 to 3 of 3
| Title | Author(s) | Issue Date | |
|---|---|---|---|
MPN-545 Surpass-ET: Ropeginterferon Alfa-2b (P1101) vs. Anagrelide as Second Line Therapy in Essential Thrombocythemia Proceeding/Conference:Clinical Lymphoma Myeloma and Leukemia | 2022 | ||
| 2021 | |||
| 2022 |
